Advisor Partners LLC Abb Vie Inc. Transaction History

Advisor Partners LLC

$1.42 Billion
Q2 2022

A detailed history of Advisor Partners LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Advisor Partners LLC holds 67,211 shares of ABBV stock, worth $13.5 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares

67,211

Previous 65,720 2.27%

Holding current value

$13.5 Million

Previous $10.7 Million 3.38%

% of portfolio

0.72%

Previous 0.67%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$137.62 - $174.96 $205,191 - $260,865	1,491 Added 2.27%	67,211 $10.3 Million
Q1 2022 Apr 27, 2022	BUY	$131.98 - $163.75 $60,974 - $75,652	462 Added 0.71%	65,720 $10.7 Million
Q4 2021 Feb 04, 2022	BUY	$107.43 - $135.93 $161,359 - $204,166	1,502 Added 2.36%	65,258 $8.84 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $165,558 - $187,933	-1,556 Reduced 2.38%	63,756 $6.88 Million
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $148,556 - $165,500	1,412 Added 2.21%	65,312 $7.36 Million
Q1 2021 Jun 01, 2021	BUY	$102.3 - $112.62 $12,992 - $14,302	127 Added 0.2%	63,900 $6.92 Million
Q4 2020 Feb 17, 2021	SELL	$80.49 - $108.67 $119,366 - $161,157	-1,483 Reduced 2.27%	63,773 $6.83 Million
Q3 2020 Nov 19, 2020	SELL	$85.91 - $100.83 $380,924 - $447,080	-4,434 Reduced 6.36%	65,256 $5.72 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $948,747 - $1.27 Million	12,931 Added 22.78%	69,690 $6.84 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $617,265 - $935,850	9,570 Added 20.28%	56,759 $4.32 Million
Q4 2019 Jan 24, 2020	BUY	$72.13 - $90.25 $349,974 - $437,893	4,852 Added 11.46%	47,189 $4.21 Million
Q3 2019 Oct 16, 2019	BUY	$62.98 - $75.72 $229,625 - $276,075	3,646 Added 9.42%	42,337 $3.21 Million
Q2 2019 Jul 26, 2019	BUY	$65.7 - $83.98 $15,636 - $19,987	238 Added 0.62%	38,691 $2.81 Million
Q1 2019 Apr 23, 2019	SELL	$77.14 - $90.79 $802,795 - $944,851	-10,407 Reduced 21.3%	38,453 $3.1 Million
Q4 2018 Jan 29, 2019	BUY	$77.85 - $96.01 $570,173 - $703,177	7,324 Added 17.63%	48,860 $4.5 Million
Q3 2018 Nov 06, 2018	SELL	$88.91 - $98.84 $40,809 - $45,367	-459 Reduced 1.09%	41,536 $3.93 Million
Q2 2018 Jul 25, 2018	BUY	$89.78 - $106.23 $51,264 - $60,657	571 Added 1.38%	41,995 $3.89 Million
Q1 2018 May 03, 2018	BUY	$92.01 - $123.21 $239,133 - $320,222	2,599 Added 6.69%	41,424 $3.92 Million
Q4 2017 Jan 26, 2018	BUY	$89.56 - $98.21 $353,493 - $387,634	3,947 Added 11.32%	38,825 $4.06 Million
Q3 2017 Nov 03, 2017	BUY	$69.85 - $89.22 $2.44 Million - $3.11 Million	34,878	34,878 $3.1 Million

Others Institutions Holding ABBV

# of Institutions

3,785

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.82M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $355B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Partners LLC with notifications on news.

Account

Advisor Partners LLC Abb Vie Inc. Transaction History